152 related articles for article (PubMed ID: 28781279)
1. [Donor cell-derived hematological malignancies after allogeneic hematopoietic stem cell transplantation].
Kato M
Rinsho Ketsueki; 2017; 58(7):813-817. PubMed ID: 28781279
[TBL] [Abstract][Full Text] [Related]
2. Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Hertenstein B; Hambach L; Bacigalupo A; Schmitz N; McCann S; Slavin S; Gratwohl A; Ferrant A; Elmaagacli A; Schwertfeger R; Locasciulli A; Zander A; Bornhäuser M; Niederwieser D; Ruutu T;
Haematologica; 2005 Jul; 90(7):969-75. PubMed ID: 15996934
[TBL] [Abstract][Full Text] [Related]
3. Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.
Bouvier A; Ribourtout B; François S; Orvain C; Paz DL; Beucher A; Guérard A; Guardiola P; Ugo V; Blanchet O; Geneviève F; Schmidt A; Hunault-Berger M
Eur J Haematol; 2018 Oct; 101(4):570-574. PubMed ID: 30007088
[TBL] [Abstract][Full Text] [Related]
4. Donor cell leukemia: a review.
Wiseman DH
Biol Blood Marrow Transplant; 2011 Jun; 17(6):771-89. PubMed ID: 20951819
[TBL] [Abstract][Full Text] [Related]
5. Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature.
Wang E; Hutchinson CB; Huang Q; Lu CM; Crow J; Wang FF; Sebastian S; Rehder C; Lagoo A; Horwitz M; Rizzieri D; Yu J; Goodman B; Datto M; Buckley P
Am J Clin Pathol; 2011 Apr; 135(4):525-40. PubMed ID: 21411775
[TBL] [Abstract][Full Text] [Related]
6. European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation.
Engel N; Rovo A; Badoglio M; Labopin M; Basak GW; Beguin Y; Guyotat D; Ljungman P; Nagler A; Schattenberg A; Schroeder T; Schroyens W; Tischer J; Socie G; Kolb HJ; Tichelli A; Salooja N; Duarte RF;
Leukemia; 2019 Feb; 33(2):508-517. PubMed ID: 30050122
[TBL] [Abstract][Full Text] [Related]
7. True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report.
Hoffmann M; Banz Y; Halter J; Schoumans J; Tchinda J; Bacher U; Pabst T
Curr Oncol; 2024 Apr; 31(4):2067-2075. PubMed ID: 38668056
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia.
Rodríguez-Macías G; Martínez-Laperche C; Gayoso J; Noriega V; Serrano D; Balsalobre P; Muñoz-Martínez C; Díez-Martín JL; Buño I
Hum Pathol; 2013 Aug; 44(8):1696-9. PubMed ID: 23465275
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
[TBL] [Abstract][Full Text] [Related]
10. Donor cell-derived acute lymphocytic leukemia after allogeneic stem cell transplantation for multiple myeloma.
Igarashi N; Chou T; Hirose T; Imai Y; Ishiguro T; Nemoto K
Int J Hematol; 2009 Oct; 90(3):378-382. PubMed ID: 19693451
[TBL] [Abstract][Full Text] [Related]
11. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning regimen in children: a single-center experience.
Strullu M; Rialland F; Cahu X; Brissot E; Corradini N; Thomas C; Blin N; Rialland X; Méchinaud F; Mohty M
Eur J Haematol; 2012 Jun; 88(6):504-9. PubMed ID: 22372430
[TBL] [Abstract][Full Text] [Related]
13. Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation.
Kato M; Yamashita T; Suzuki R; Matsumoto K; Nishimori H; Takahashi S; Iwato K; Nakaseko C; Kondo T; Imada K; Kimura F; Ichinohe T; Hashii Y; Kato K; Atsuta Y; Taniguchi S; Fukuda T
Leukemia; 2016 Aug; 30(8):1742-5. PubMed ID: 26867671
[No Abstract] [Full Text] [Related]
14. Donor Cell-Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic Review.
Suárez-González J; Martínez-Laperche C; Kwon M; Balsalobre P; Carbonell D; Chicano M; Rodríguez-Macías G; Serrano D; Gayoso J; Díez-Martín JL; Buño I
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1505-1513. PubMed ID: 29410295
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
16. Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report.
Ruiz-Delgado GJ; León Peña AA; Gómez-de-León A; Ruiz-Argüelles GJ
Hematology; 2016 Sep; 21(8):470-3. PubMed ID: 26914843
[TBL] [Abstract][Full Text] [Related]
17. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
[TBL] [Abstract][Full Text] [Related]
18. Donor cell leukemia/myelodysplastic syndrome after allogeneic stem cell transplantation: a rare phenomenon with more challenges for hematologists.
Zhang S; Li L; Cao W; Li Y; Jiang Z; Yu J; Wan D
Hematology; 2021 Dec; 26(1):648-651. PubMed ID: 34474660
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20. Transmission of an expanding donor-derived del(20q) clone through allogeneic hematopoietic stem cell transplantation without the development of a hematologic neoplasm.
Aikawa V; Porter D; Luskin MR; Bagg A; Morrissette JJ
Cancer Genet; 2015 Dec; 208(12):625-9. PubMed ID: 26628205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]